Jan 23, 2009 9:13am EST OPKO Receives FDA 510(k) Clearance for Spectral OCT SLO Combination Imaging System
Dec 04, 2008 9:16am EST OPKO Health Announces Completion of Enrollment for Its Phase III Clinical Trial of Bevasiranib for Treatment of AMD
Oct 02, 2008 1:12pm EDT OPKO Acquires Worldwide Ophthalmic Rights to Teva's Budesonide for Inflammatory and Allergic Ocular Conditions
Jun 03, 2008 11:51am EDT Newly Published Study Shows OPKO's siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
Mar 18, 2008 7:58am EDT OPKO Health Announces Issuance of U.S. Patent Covering the Use and Administration of Certain Anti-VEGF siRNA's, Including Its Phase III Compound Bevasiranib